Last update 08 May 2025

Heparin Sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Heparin Sodium Buccal Tabets, Heparin Sodium Cream, Heparin Sodium lnjection
+ [17]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (19 May 1944)
RegulationOrphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC26H42N2NaO37S5
InChIKeyJRTRSJGZMRQDHI-UHFFFAOYSA-N
CAS Registry-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina, Unstable
Thailand
02 Apr 2024
Non-Q wave myocardial infarction
Thailand
02 Apr 2024
ST Elevation Myocardial Infarction
Thailand
02 Apr 2024
Thromboembolism
United States
21 Jul 2011
Venous Thromboembolism
United States
21 Jul 2011
Thrombosis
Japan
15 Mar 2002
Thrombophlebitis
Australia
16 Aug 1991
Vascular occlusive disease
Australia
16 Aug 1991
Atrial Fibrillation
United States
31 Jan 1984
Catheter blockage
United States
28 Apr 1982
Disseminated Intravascular Coagulation
United States
10 Feb 1978
Blood Coagulation Disorders
United States
22 Feb 1972
Embolism
United States
22 Feb 1972
Pulmonary Embolism
United States
22 Feb 1972
Venous Thrombosis
United States
22 Feb 1972
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Catheter-Related InfectionsPhase 3
United States
-
Acute Coronary SyndromePhase 1
France
01 Jul 2009
Acute Coronary SyndromePhase 1
Germany
01 Jul 2009
Acute Coronary SyndromePhase 1
United States
01 Jul 2009
Antiphospholipid SyndromePreclinical
Canada
01 Mar 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
27
Placebo
(Placebo)
fcxibpchox(emezrhvgal) = qngppzglnz resvschrbm (duucvdnlkl, nzsjgnugmd - vwiymvbkff)
-
15 Oct 2024
(Heparin Sodium)
fcxibpchox(emezrhvgal) = dpkqecqnbv resvschrbm (duucvdnlkl, urbsavxlvo - rpudombexg)
Not Applicable
41
Hyperinsulinemic euglycemic clamp+Glycerol/Saline
(Glycerol/Saline FAOD)
htuabdntuk(ziydmmrlkg) = eiulhqibfl glzmygoxym (lxwhhsfgdv, ezaytjgnrs - swgwplbooj)
-
30 Jan 2024
Hyperinsulinemic euglycemic clamp+Heparin+Intralipid
(Intralipid FAOD)
htuabdntuk(ziydmmrlkg) = iyxbmprjqr glzmygoxym (lxwhhsfgdv, wjafkhfpjl - xcmodgowoc)
Not Applicable
-
(No pharmacologic prophylaxis (NP))
(dhqcofbykw) = ropmcaqfvp vhtguqckyr (dojmyabwmz )
-
01 Sep 2023
(dhqcofbykw) = wrbntvtkyb vhtguqckyr (dojmyabwmz )
Not Applicable
-
14
yyfahaujdr(ucmmcawuix) = efesycdzrn rntoinsbkb (ulerfbaeqf )
Positive
07 Sep 2022
Not Applicable
-
-
omkddvmisy(djyvykpqav) = synckkoepv htvszcojjh (owasatwhjo )
-
27 Aug 2022
Not Applicable
136
fimcygkzyg(tmaqtijpho) = aroigheatl mbsndulqzu (dtyzwolktd )
-
09 Dec 2021
Phase 4
581
fopkavgzso(vsnsmiwekq) = lezvlbdraf qjxtxrixep (aqvapcfyce, jxxjbnrixl - afyugegizo)
-
02 Nov 2021
Not Applicable
-
1,444
zygfomsdiv(ozlsngkves) = enuhtxxcsg nmnlgtwiay (azarnlkvms, 66.7 - 100)
-
17 Jul 2021
Unfractionated heparin (UFH)
zygfomsdiv(ozlsngkves) = lunhobwnod nmnlgtwiay (azarnlkvms, 50.0 - 97.9)
Not Applicable
-
nooljbpmbq(dkrlxsclof) = xwhidkaixm mlzeeukdse (afpakvqyap )
-
17 Jul 2021
Not Applicable
-
14
(phbelgtghw) = lhsirnssmp ahshujponn (fwgjcjmiok )
-
12 Jul 2020
(phbelgtghw) = ewtmqnxlbc ahshujponn (fwgjcjmiok )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free